Watchlist

Watchlist
Adamas Pharmaceuticals, Inc. (ADMS)
Adamas Pharmaceuticals, Inc. (ADMS)
Healthcare events next week
Upcoming events in healthcare next week: More news on: Zogenix, Inc., Omnicell, Inc., Ultragenyx Pharmaceutical Inc., Healthcare stocks news, Read more …
Biotech Forum Daily Digest: Some Recent Positives For Egalet
The road that is built in hope is more pleasant to the traveler than the road built in despair, even though they both lead to the same destination . - Marion Zimmer Bradley, The Fall Of Atlantis Biotech continues to be directionless in trading. The main biotech indices are close t…
Premarket Gainers as of 9:05 am
CAPR +29% as FDA signs off on registration study of Capricor's DMD candidate CAP-1002. More news on: Capricor Therapeutics, Inc., Digital Power Corporation, Marathon Patent Group, Inc., Stocks on the move, Read more …
Premarket analyst action - healthcare
Madrigal Pharmaceuticals (NASDAQ: MDGL ) initiated with Buy rating and $54 (17% upside) price target by H.C. Wainwright. More news on: Madrigal Pharmaceuticals, Inc., Xencor, Inc., Adamas Pharmaceuticals, Inc., Healthcare stocks news, Read more …
Can The Big Rally In Adamas Pharmaceuticals Continue?
"A dean is the conductor of an orchestra made up entirely of composers." - Mark William Roche I hope the entire Seeking Alpha community had a joyous and relaxing Thanksgiving with friends and family. Source: Seeking Alpha I just want to provide a quick update on Adamas Pharmaceutica…
Biotech Forum Daily Digest: Why Adamas Is Soaring
Only a fool would underestimate a man with nothing to lose . - Lance Conrad, The Price of Loyalty Thanks to a nice rally on Friday, the biotech sector managed to post a slight gain in the week just passed. Tax reform efforts have begun in earnest in congress. I think the drug and …
Biotech Forum Daily Digest: Behind Neurocrine's Big 3rd Quarter Beat
The curious mind embraces science; the gifted and sensitive, the arts; the practical, business; the leftover becomes an economist " - Nassim Nicolaus Taleb It looks like the biotech sector is on its way to posting another down week. The main biotech indices are back down to their levels o…
Adamas Pharmaceuticals' (ADMS) CEO Gregory Went on Q3 2017 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS) Q3 2017 Earnings Conference Call November 02, 2017 04:30 PM ET Executives Ashleigh Barreto - IR and Corporate Communications Gregory Went - Chairman and CEO Alfred Merriweather - CFO Richard King - COO Rajiv Patni - CMO Analysts Ken C…
Adamas Pharma misses by $0.06
Adamas Pharma (NASDAQ: ADMS ): Q3 EPS of -$1.04 misses by $0.06 . More news on: Adamas Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more …
Notable earnings after Thursday's close
AAPL , ACET , ACIA , ACLS , ADMS , AGII , AGO , AHT , AIG , AIZ , AKR , AMBR , AMH , AMN , ANET , AOSL , APPN , ATGE , ATUS , ATVI , AUTO , AVD , BIO , BKH , BL , BNFT , BOOT , BRKR , CALD , CARA , CARB , CATM , CBL , CBS , CC , CDR , CECO , CERS , CHU…
Adamas Pharmaceuticals, Inc.: Substantial Upside For A Misunderstood Drug Maker
Note: References are noted by parentheticals - (1) - and end notes by superscript - 1 . We are long shares of Adamas Pharmaceuticals (NYSE: ADMS ), a small-cap drug company on the eve of launching its first product: a treatment called Gocovri for patients with Parkinsons diseas…
Adamas Pharmaceuticals, Inc. (ADMS)